Your browser doesn't support javascript.
loading
Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction.
Florian, David C; Bennett, Natalie E; Odziomek, Mateusz; Baljon, Jessalyn J; Wehbe, Mohamed; Merkel, Alyssa R; Fischer, Melissa A; Savona, Michael R; Rhoades, Julie A; Guelcher, Scott A; Wilson, John T.
Afiliação
  • Florian DC; Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee.
  • Bennett NE; Center for Bone Biology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Odziomek M; Center for Bone Biology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Baljon JJ; Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, Tennessee.
  • Wehbe M; Program in Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee.
  • Merkel AR; Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee.
  • Fischer MA; Center for Bone Biology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Savona MR; Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee.
  • Rhoades JA; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Tennessee.
  • Guelcher SA; Center for Bone Biology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Wilson JT; Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, Tennessee.
Cancer Res Commun ; 3(2): 223-234, 2023 02.
Article em En | MEDLINE | ID: mdl-36968140

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / Neoplasias Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / Neoplasias Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article